Summary
Studies were undertaken to test the susceptibility of individual T cell subpopulations to retroviral-mediated gene transduction. Gene transfer into human tumor-infiltrating lymphocytes (TIL) or peripheral blood mononuclear cells (PBMC) was carried out by transduction with an amphotropic murine retroviral vector (LNL6 or N2) containing the bacterialneo R gene. The presence of theneo R gene in the TIL population was demonstrated by Southern blot analysis, detection of the enzymatic activity of the gene product and by the ability of transduced TIL to proliferate in high concentrations of G418, a neomycin analog that is toxic to eukaryotic cells. The presence of theneo R gene in TIL did not alter their proliferation or interleukin-2 dependence compared to nontransduced TIL. The differential susceptibility of CD4+ and CD8+ lymphoid cells to the retro-virus-mediated gene transfer was then tested. Transduction of heterogeneous TIL cultures containing both CD4+ and CD8+ cells resulted in gene insertion into both T cell subsets with no preferential transduction frequency into either CD4+ or CD8+ cells. In other experiments highly purified CD4+ and CD8+ T cell subpopulations from either TIL or PBMC could be successfully transduced with theneo R gene as demonstrated by Southern blot analysis and detection of the gene product neophosphotransferase activity. No such activity or vector DNA could be detected in controls of nontransduced cells. In these highly purified cell subsets the distinctive T cell phenotypic markers were continually expressed after transduction, G418 selection and long-term growth. Clinical trials have begun in patients with advanced cancer using heterogeneous populations of CD4+ and CD8+ gene-modified TIL.
Similar content being viewed by others
References
Belldegrun A, Muul LM, Rosenberg SA (1988) Interleukin expanded tumor infiltrating lymphocytes in human renal cell cancer: isolation, characterization and antitumor activity. Cancer Res 48: 206
Bender MA, Palmer TD, Gelinas RE, Miller AD (1987) Evidence that the packaging signal of moloney murine leukemia virus extends into gag region. J Virol 61: 1639
Boyum A (1968) Isolation of leukocytes from human blood. Scand J Clin Lab Invest 21 [Suppl. 97] 77
Bubenik J, Voitenok NN, Kieler J, Prassolov VS, Chumakow PM, Bubenikova J, Simova J, Jandlova T (1988) Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in Nu/Nu mice. Immunol Lett 19: 279
Cepko CL, Roberts BE, Mulligan RC (1984) Construction and application of a highly transmissible murine retrovirus shuttle vector. Cell 37: 1053
Chang JM, Johnson GR (1989) Gene transfer into hemopoietic stem cells using retroviral vectors. Int J Cell Cloning 7: 264
Eglitis MA, Kantoff P, Gilboa E, Anderson WF (1985) Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science 230: 1395
Fisher B, Packard BS, Read EJ, Carrasquillo JA, Carter CS, Topalian SL, Yang JC, Yolles P, Larson SM, Rosenberg SA (1989) Tumor localization of adoptively transferred indium-III labeled tumor infiltrating lymphoctes in patients with metastatic melanoma. J Clin Oncol 7: 250
Hock RA, Miller AD (1986) Retrovirus-mediated transfer and expression of drug resistance genes in human hematopoietic progenitor cells. Nature 320: 275
Itoh K, Tilden AB, Balch CM (1986) Interleukin-2 activation of cytotoxic T lymphocytes infiltrating into human metastatic melanomas. Cancer Res 46: 3011
Joyner A, Keller G, Phillips RA, Bernstein A (1983) Retrovirus transfer of bacterial gene into mouse haematopoietic progenitor cells. Nature 305: 556
Kantoff PW, Kohn DB, Mitsuy H, Armentano D, Sieberg M, Zwiebel JA, Eglitis MA, McLachlin Mc, Wiginton DA, Hutton JJ, Horowitz SD, Gilboa E, Blaese RM, Anderson WF (1986) Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 83: 6563
Kantoff PW, Gillio AP, McLachlin JR, Bardignon C, Eglitis MA, Kernan NA, Moen RC, Kohn DB, Yu S, Karson E, Karlsson S, Zwievel JA, Gilboa E, Blaese RM, Nienhuis A, O'Reilly RJ, Anderson WF (1987) Expression of human adenosine deaminase in nonhuman primates after retrovirus-mediated gene transfer. J Exp Med 166: 219
Kasid A, Morecki S, Aebersold P, Cornetta K, Culver K, Freeman S, Director E, Lotze MT, Blaese MA, Anderson WF, Rosenberg SA (1990) Human gene transfer: characterization of human tumor infiltrating lymphocytes as vehicles after retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA 87: 473
Keller G, Paige C, Gilboa E, Wagner EF (1985) Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent hematopoietic precursors. Nature 318: 149
Kohn DB, Kantoff PW, Eglitis MA, McLachlin JR, Moen RC, Karson E, Zwiebel JA, Nienhuis A, Karlsson S, O'Reilly R, Gillio A, Bordignon C, Gilboa E, Zanjani ED, Blaese RM, Anderson WF (1987) Retroviral-mediated gene transfer into mammalian cells. Blood cells 13: 285
Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinett SM, Pinto CE, Gifford J, Davidson E, Grove B, Callahan RJ, Strauss HW (1989) Tumor-infiltrating lymphocytes and interleukin-2 in treatment of patients with advanced cancer. Lancet 1: 577
Losardo JE, Cupelli LA, Short MK, Berman JW, Lenz J (1989) Differences in activities of murine retroviral long terminal repeats in cytotoxic T lymphocytes and T-lymphoma cells. J Virol 63: 1087
McDonald HR, Cerottini JC, Ryser JE, Maryanski JL, Taswell C, Widmer MB, Brunner KT (1980) Quantitation and cloning of cytolytic T lymphocytes and their precursors. Immunol Rev 51: 93
Miller DA, Buttimore C (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6: 2895
Muul LM, Spiess PJ, Director EP, Rosenberg SA (1987) Identification of specific cytolytic immune responses against autologous tumor in human bearing malignant melanoma. J Immunol 138: 989
Nishihara K, Miyatake S, Sakata T, Yamashita J, Kikuchi H, Kawade Y, Zu Y, Namba Y, Hanaoka M, Watanabe Y (1988) Augmentation of tumor targeting in a line of Glioma-specific mouse cytotoxic T-lymphocytes by retroviral expression of mouse α-interferon complementing DNA. Cancer Res 48: 4730
Reimann J, Heeg K, Wagner H, Keller G, Wagner EF (1986) Introduction of a selectable gene into murine T-lymphoblasts by retroviral vector. J Immunol Methods 89: 93
Reiss B, Sprengel R, Will H, Schaller H (1984) A new sensitive method of qualitative and quantitative assay of neomycin phosphotransferase in crude cell extracts. Gene 30: 211
Rosenberg SA, Spiess P, Laffeniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 223: 1318
Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST, Simon P, Lotze MT, Yang JC, Seipp CA, Simpson C, Carter C, Bock S, Schwartzentruber D, Wei JP, White DE (1988) Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. N Engl J Med 319: 1676
Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF (1990) Gene transfer into humans — immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323–570
Schuening FG, Storb R, Stead RB, Goehle S, Nash R, Miller AD (1989) Improved retroviral transfer of genes into canine hematopoietic progenitor cells kept in long term marrow culture. Blood 74: 152
Spiess PJ, Yang JC, Rosenberg SA (1987) In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. JNCI 79: 1067
Springett GM, Moen RC, Anderson S, Blaese MR, Anderson WF (1989) Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol 63: 3865
Steffen D, Weinberg RA (1978) The integrated genome of murine leukemia virus. Cell 15: 1003
Topalian SL, Muul SM, Solomon D, Rosenberg SA (1987) Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J Immunol Methods 102: 127
Uchida N, Cone RD, Freeman GJ, Mulligan RC, Cantor H (1986) High efficiency gene transfer into murine T cell clones using retroviral vector. J Immunol 136: 1876
Varmus HE, Quintrell N, Ortiz S (1981) Retro viruses as mutagens: insertion and excision of a nontransforming provirus alter expression of resident transforming provirus. Cell 25: 23
Williams DA, Orkin SH, Mulligan RC (1986) Retrovirus-mediated transfer of human adenosine deaminase gene sequences into cells in culture and into murine hematopoietic cells in vivo. Proc Natl Acad Sci USA 83: 2566
Author information
Authors and Affiliations
Additional information
Current address: Bone Marrow Transplantation, Hadassah University Hospital, 91120 Jerusalem, Israel
Rights and permissions
About this article
Cite this article
Morecki, S., Karson, E., Cornetta, K. et al. Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunol Immunother 32, 342–352 (1991). https://doi.org/10.1007/BF01741329
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01741329